Browne JL, Holmes-Truscott E, Ventura A, Hendrieckx C, Pouwer F, Speight J. Cohort profiles of the cross-sectional and prospective participant groups in the second Diabetes MILES – Australia (MILES-2) study. BMJ Open, 2017; doi: 10.1136/bmjopen-2016-012926.
Craike MJ, Mosley K, Browne JL, Pouwer F, Speight J. Associations between physical activity and depressive symptoms by weight status among adults with type 2 diabetes: results from Diabetes MILES – Australia. Journal of Physical Activity & Health, 2017; 14(3): 196-202.
Dennicka KJ, Sturta J, Speight J. What is diabetes distress and how can we measure it? A narrative review. Journal of Diabetes and Its Complications, 2017; 31(5): 898-911
Dunning T, Speight J, Bennett C. Language, the ‘diabetes restricted code/dialect ’and what it means for people with diabetes and clinicians. The Diabetes Educator, 2017; 43(1): 18-26.
Furler J, O’Neal DN, Speight J, Manski-Nankervis J, Gorelik A, Holmes-Truscott E, Ginnivan LE, Young D, Best J, Patterson E, Liew D, Segal L, May CR, Blackberry I. Supporting insulin initiation in type 2 diabetes in primary care: results of the Stepping Up pragmatic cluster randomised controlled clinical trial. BMJ Open, 2017; 7(2): e012926. doi: 10.1136/bmjopen-2016-012926.
Halliday J, Hendrieckx C, Busija L, Browne J, Nefs G, Pouwer F, Speight J. Validation of the WHO-5 as a first-step screening instrument for depression in adults with diabetes: Results from Diabetes MILES – Australia. Diabetes Research and Clinical Practice, doi: 10.1016/j.diabres.2017.07.005
Hendrieckx C, Hagger V, Jenkins A, Skinner TC, Pouwer F, Speight J. Severe hypoglycemia, impaired awareness of hypoglycemia and self-monitoring in adults with type 1 diabetes: Results of the Diabetes MILES – Australia. Journal of Diabetes and its Complications, 2017; 31(3): 577-582 doi: 10.1016/j.jdiacomp.2016.11.013.
Hendrieckx C, Poole LA, Sharifi A, Jayawardene D, Loh MM, Horsburgh JC, Bach LA, Colman PG, Kumareswaran K, Jenkins AJ, MacIsaac RJ, Ward GM, Grosman B, Roy A , O’Neal DN, Speight J. ‘It is definitely a game changer’: a qualitative study of experiences with in-home overnight closed-loop technology among adults with type 1 diabetes. Diabetes Technology & Therapy, 2017; 9(7): 410-416 doi: 10.1016/j.jdiacomp.2016.11.013.
Hilliard M, Hagger V, Hendrieckx C, Anderson B, Trawley S, Jack M, Pouwer F, Skinner T, Speight J. Strengths, risk factors, and resilient outcomes in adolescents with type 1 diabetes: results from Diabetes MILES Youth – Australia. Diabetes Care, 2017; 40(7): 849-855.
Holmes-Truscott E, Pouwer F, Speight J. Assessing psychological insulin resistance in type 2 diabetes: a critical comparison of measures. Current Diabetes Reports, 2017; 17 (7): 46.
Holmes-Truscott E, Furler J, Speight J, O’Neal D. Predictors of insulin uptake among adults with type 2 diabetes in the Stepping Up Study Journal. Diabetes Research and Clinical Practice, 2017; online ahead of print.
Lake AJ, Browne JL, Rees G, Speight J. Measuring quality of life: the importance of thinking in more than two dimensions. Journal of Diabetes and its Complications, 2017; 31(6): 997-1006.
Morrison M, Audehm R, Barry A, Hendrieckx C, Nankervis A, Porter C, Scibilia R, Ross GP. Resources to support preconception care for women with diabetes. Diabetes & Primary Care Australia, 2017; 2: 50-3
Rees G, O’Hare F, Saeed M, Sudholz B, Sturrock B, Xie J, Speight J, Lamoureux E. Problem-solving therapy for adults with diabetic retinopathy and diabetes-specific distress: a pilot randomised controlled trial. BMJ Open Diabetes Research & Care, 2017; 5(1): e000307, doi: 10.1136/bmjdrc-2016-000307
Speight J. Letter to editor: Behavioural innovation is key to improving the health of one million Australians living with type 2 diabetes. Medical Journal of Australia, 2017; 206(3): 142.
Speight J. Measuring quality of life: the importance of thinking in more than two dimensions. BMJ, 2017; 354:i3816